Skip to main content
Erschienen in: Archives of Virology 12/2013

01.12.2013 | Original Article

A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS)

verfasst von: Takeshi Ihara, Norihiro Furusyo, Takeo Hayashi, Kazuhiro Toyoda, Masayuki Murata, Jun Hayashi

Erschienen in: Archives of Virology | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

Human parvovirus B19 infection occurs by droplet nuclei through the respiratory tract and causes a wide range of diseases. It can be transmitted through blood transfusion from asymptomatic blood donors. This study was done to investigate the parvovirus B19 infection rate of a group of healthy Japanese residents. Of 2,081 blood samples tested, 15 (0.72 %) were positive for parvovirus B19 IgM, 1,412 (67.9 %) for B19 virus IgG, and 4 (0.2 %) for parvovirus B19 DNA. About half of all women of childbearing age were susceptible to parvovirus B19 infection. No relationship was found between the frequency of symptoms and the prevalence of parvovirus B19 IgG and IgM, suggesting that there are asymptomatic carriers in the healthy Japanese population. There is a risk of parvovirus B19 infection by blood transfusion from asymptomatic donors and that pregnant women are at high risk for parvovirus B19 infection.
Literatur
1.
Zurück zum Zitat Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–117PubMedCrossRef Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–117PubMedCrossRef
2.
Zurück zum Zitat White DG, Mortimer PP, Blake DR, Woolf AD, Cohen BJ, Bacon PA (1985) Human parvovirus arthropathy. Lancet 325:419–421CrossRef White DG, Mortimer PP, Blake DR, Woolf AD, Cohen BJ, Bacon PA (1985) Human parvovirus arthropathy. Lancet 325:419–421CrossRef
3.
Zurück zum Zitat Broliden K, Tolfvenstam T, Norbeck O (2006) Clinical aspects of parvovirus B19 infection. J Intern Med 260:285–304PubMedCrossRef Broliden K, Tolfvenstam T, Norbeck O (2006) Clinical aspects of parvovirus B19 infection. J Intern Med 260:285–304PubMedCrossRef
4.
Zurück zum Zitat Yamamoto T, Ise K, Nakashima K, Hayashi J, Nunoue T, Kashiwagi S (2006) Parvovirus B19 as a trigger for spontaneous bacterial peritonitis in a patient with cirrhotic ascites. Am J Gastroenterol 91:1857–1859 Yamamoto T, Ise K, Nakashima K, Hayashi J, Nunoue T, Kashiwagi S (2006) Parvovirus B19 as a trigger for spontaneous bacterial peritonitis in a patient with cirrhotic ascites. Am J Gastroenterol 91:1857–1859
5.
Zurück zum Zitat Ogawa E, Otaguro S, Murata M, Kainuma M, Sawayama Y, Furosyo N, Hayashi J (2006) Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection. J Infect Chemother 14:377–382CrossRef Ogawa E, Otaguro S, Murata M, Kainuma M, Sawayama Y, Furosyo N, Hayashi J (2006) Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection. J Infect Chemother 14:377–382CrossRef
6.
Zurück zum Zitat Servey JT, Reamy BV, Hodge J (2007) Clinical presentation of parvovirus B19 infection. Am Fam Physician 75:373–376PubMed Servey JT, Reamy BV, Hodge J (2007) Clinical presentation of parvovirus B19 infection. Am Fam Physician 75:373–376PubMed
7.
Zurück zum Zitat Tolfvenstam T, Broliden K (2009) Parvovirus B19 infection. Semin Fetal Neonatal Med 14:218–221PubMedCrossRef Tolfvenstam T, Broliden K (2009) Parvovirus B19 infection. Semin Fetal Neonatal Med 14:218–221PubMedCrossRef
8.
Zurück zum Zitat Yoto Y, Kudoh T, Haseyama K, Suzuki N, Oda T, Katoh T, Takahashi T, Sekiguchi S, Chiba S (1995) Incidence of human parvovirus B19 DNA detection in blood donors. Br J Hematol 91:1017–1018CrossRef Yoto Y, Kudoh T, Haseyama K, Suzuki N, Oda T, Katoh T, Takahashi T, Sekiguchi S, Chiba S (1995) Incidence of human parvovirus B19 DNA detection in blood donors. Br J Hematol 91:1017–1018CrossRef
9.
Zurück zum Zitat Wakamatsu C, Takakura F, Kojima E, Kiriyama Y, Goto N, Matsumoto K, Oyama M, Sato H, Okochi K, Maeda Y (1999) Screening of blood donors for human parvovirus B19 and characterization of the results. Vox Sang 76:14–21PubMedCrossRef Wakamatsu C, Takakura F, Kojima E, Kiriyama Y, Goto N, Matsumoto K, Oyama M, Sato H, Okochi K, Maeda Y (1999) Screening of blood donors for human parvovirus B19 and characterization of the results. Vox Sang 76:14–21PubMedCrossRef
10.
Zurück zum Zitat Jordan J, Tiangco B, Kiss J, Koch W (1998) Human Parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang 75:97–102PubMedCrossRef Jordan J, Tiangco B, Kiss J, Koch W (1998) Human Parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang 75:97–102PubMedCrossRef
11.
Zurück zum Zitat Kashiwagi S, Hayashi J, Ikematsu H, Nomura H, Kusaba T, Shingu T, Hayashida K, Kaji M (1983) An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan. Am J Epidemiol 118:787–794PubMed Kashiwagi S, Hayashi J, Ikematsu H, Nomura H, Kusaba T, Shingu T, Hayashida K, Kaji M (1983) An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan. Am J Epidemiol 118:787–794PubMed
12.
Zurück zum Zitat Ohnishi H, Sawayama Y, Furusyo N, Maeda S, Tokunaga S, Hayashi J (2010) Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis: the Kyushu and Okinawa population study (KOPS). J Atheroscler Thromb 17:751–758PubMedCrossRef Ohnishi H, Sawayama Y, Furusyo N, Maeda S, Tokunaga S, Hayashi J (2010) Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis: the Kyushu and Okinawa population study (KOPS). J Atheroscler Thromb 17:751–758PubMedCrossRef
13.
Zurück zum Zitat Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J (2011) Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa population study (KOPS). Diabetologia 54:3028–3036PubMedCrossRef Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J (2011) Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa population study (KOPS). Diabetologia 54:3028–3036PubMedCrossRef
14.
Zurück zum Zitat Baylis SA, Shah N, Minor PD (2004) Evaluation of different assays for the detection of Parvovirus B19 DNA in human plasma. J Virol Methods 121:7–16PubMedCrossRef Baylis SA, Shah N, Minor PD (2004) Evaluation of different assays for the detection of Parvovirus B19 DNA in human plasma. J Virol Methods 121:7–16PubMedCrossRef
15.
Zurück zum Zitat Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M (2001) A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA. J Virol Methods 92:183–191PubMedCrossRef Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M (2001) A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA. J Virol Methods 92:183–191PubMedCrossRef
16.
Zurück zum Zitat Daly P, Corcoran A, Mahon BP, Doyle S (2002) High-sensitivity PCR detection of Parvovirus B19 in plasma. J Clin Microbiol 40:1958–1962PubMedCrossRef Daly P, Corcoran A, Mahon BP, Doyle S (2002) High-sensitivity PCR detection of Parvovirus B19 in plasma. J Clin Microbiol 40:1958–1962PubMedCrossRef
17.
Zurück zum Zitat Yaegashi N, Niinuma T, Chisaka H, Uehara S, Okamura K, Shinkawa O, Tsunoda A, Moffatt S, Sugamura K, Yamaji A (1999) Serologic study of human parvovirus B19 in pregnancy in Japan. J Infect 38:30–35PubMedCrossRef Yaegashi N, Niinuma T, Chisaka H, Uehara S, Okamura K, Shinkawa O, Tsunoda A, Moffatt S, Sugamura K, Yamaji A (1999) Serologic study of human parvovirus B19 in pregnancy in Japan. J Infect 38:30–35PubMedCrossRef
18.
Zurück zum Zitat Chisaka H, Ito K, Niikuma H, Sugawara J, Takano T, Murakami T, Terada Y, Okamura K, Shiroishi H, Sugamura K, Yaegashi N (2006) Clinical manifestations and outcomes of Parvovirus B19 infection during pregnancy in Japan. Tohoku J Exp Med 209:277–2833PubMedCrossRef Chisaka H, Ito K, Niikuma H, Sugawara J, Takano T, Murakami T, Terada Y, Okamura K, Shiroishi H, Sugamura K, Yaegashi N (2006) Clinical manifestations and outcomes of Parvovirus B19 infection during pregnancy in Japan. Tohoku J Exp Med 209:277–2833PubMedCrossRef
19.
Zurück zum Zitat van Rijckevorsel GG, Sonder GJ, Schim van der Loeff MF, van den Hoek JA (2009) Population-based study on the seroprevalence of Parvovirus B19 in Amsterdam. J Med Virol 81:1305–1309 van Rijckevorsel GG, Sonder GJ, Schim van der Loeff MF, van den Hoek JA (2009) Population-based study on the seroprevalence of Parvovirus B19 in Amsterdam. J Med Virol 81:1305–1309
20.
Zurück zum Zitat Mossong J, Hens N, Friederichs V, Davidkin I, Broman M, Litwinska B, Siennicka J, Trzcinska A, Van Damme P, Beutels P, Vyse A, Shkedy Z, Aerts M, Massari M, Gabutti G (2008) Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect 136:1059–1068PubMedCrossRef Mossong J, Hens N, Friederichs V, Davidkin I, Broman M, Litwinska B, Siennicka J, Trzcinska A, Van Damme P, Beutels P, Vyse A, Shkedy Z, Aerts M, Massari M, Gabutti G (2008) Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect 136:1059–1068PubMedCrossRef
21.
Zurück zum Zitat Röhrer C, Gärtner B, Sauerbrei A, Böhm S, Hottenträger B, Raab U, Thierfelder W, Wutzler P, Modrow S (2008) Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 136:1564–1575PubMedCrossRef Röhrer C, Gärtner B, Sauerbrei A, Böhm S, Hottenträger B, Raab U, Thierfelder W, Wutzler P, Modrow S (2008) Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 136:1564–1575PubMedCrossRef
22.
Zurück zum Zitat Huatuco EM, Durigon EL, Lebrun FL, Passos SD, Gazeta RE, Azevedo Neto RS, Massad E (2008) Seroprevalence of human parvovirus B19 in a suburban population in São Paulo, Brazil. Rev Saúde Pública 42:443–9 Huatuco EM, Durigon EL, Lebrun FL, Passos SD, Gazeta RE, Azevedo Neto RS, Massad E (2008) Seroprevalence of human parvovirus B19 in a suburban population in São Paulo, Brazil. Rev Saúde Pública 42:443–9
23.
Zurück zum Zitat Abarca K, Cohen BJ, Vial PA (2002) Seroprevalence of parvovirus B19 in urban Chilean children and young adults, 1990 and 1996. Epidemiol Infect 128:59–62PubMedCrossRef Abarca K, Cohen BJ, Vial PA (2002) Seroprevalence of parvovirus B19 in urban Chilean children and young adults, 1990 and 1996. Epidemiol Infect 128:59–62PubMedCrossRef
24.
Zurück zum Zitat Lin KH, You SL, Chen CJ, Wang CF, Yang CS, Yamazaki S (1999) Seroepidemiology of human parvovirus B19 in Taiwan. J Med Virol 57:169–173PubMedCrossRef Lin KH, You SL, Chen CJ, Wang CF, Yang CS, Yamazaki S (1999) Seroepidemiology of human parvovirus B19 in Taiwan. J Med Virol 57:169–173PubMedCrossRef
25.
Zurück zum Zitat Vyse AJ, Andrews NJ, Hesketh LM, Pebody R (2007) The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiol Infect 135:1354–1362PubMedCrossRef Vyse AJ, Andrews NJ, Hesketh LM, Pebody R (2007) The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiol Infect 135:1354–1362PubMedCrossRef
26.
Zurück zum Zitat Yamashita K, Matsunaga Y, Taylor-Wiedeman J, Yamazaki S (1992) A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade. Jpn J Med Sci Biol 45:49–58PubMed Yamashita K, Matsunaga Y, Taylor-Wiedeman J, Yamazaki S (1992) A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade. Jpn J Med Sci Biol 45:49–58PubMed
27.
Zurück zum Zitat Reed JL, Kucukcetin B, Koenig S (2000) Mechanisms of parvovirus B19 persistence in peripheral blood mononuclear cells. Infect Dis Rev 2:169 Reed JL, Kucukcetin B, Koenig S (2000) Mechanisms of parvovirus B19 persistence in peripheral blood mononuclear cells. Infect Dis Rev 2:169
28.
Zurück zum Zitat Satake M, Hoshi Y, Taira R, Momose S, Hino S, Tadokoro K (2011) Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion 51:1887–1895PubMedCrossRef Satake M, Hoshi Y, Taira R, Momose S, Hino S, Tadokoro K (2011) Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion 51:1887–1895PubMedCrossRef
29.
Zurück zum Zitat Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS (1989) Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 84:1114–1123PubMedCrossRef Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS (1989) Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 84:1114–1123PubMedCrossRef
30.
Zurück zum Zitat van Elsacker-Niele AM, Kroon FP, van der Ende ME, Salimans MM, Spaan WJ, Kroes AC (1996) Prevalence of Parvovirus B19 in patients infected with Human Immunodeficiency virus. Clin Infect Dis 23:1255–1260CrossRef van Elsacker-Niele AM, Kroon FP, van der Ende ME, Salimans MM, Spaan WJ, Kroes AC (1996) Prevalence of Parvovirus B19 in patients infected with Human Immunodeficiency virus. Clin Infect Dis 23:1255–1260CrossRef
31.
Zurück zum Zitat Azevedo KM, Setúbal S, Camacho LA, Velarde LG, Oliveira SA (2009) Seroepidemiological study of human parvovirus B19 among human immunodeficiency virus-infected patients in a medium-sized city in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 104:901–904PubMedCrossRef Azevedo KM, Setúbal S, Camacho LA, Velarde LG, Oliveira SA (2009) Seroepidemiological study of human parvovirus B19 among human immunodeficiency virus-infected patients in a medium-sized city in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 104:901–904PubMedCrossRef
Metadaten
Titel
A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS)
verfasst von
Takeshi Ihara
Norihiro Furusyo
Takeo Hayashi
Kazuhiro Toyoda
Masayuki Murata
Jun Hayashi
Publikationsdatum
01.12.2013
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 12/2013
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-013-1746-z

Weitere Artikel der Ausgabe 12/2013

Archives of Virology 12/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.